Nėra interneto ryšio – rodoma išsaugota puslapio versija.

Grifols S.A

USUSD
← Į Akcijų Filtrą

Grifols S.A (LSE:0RDU) — Drug Manufacturers - General. Biržų, kuriose prekiaujama bendrovės akcijomis, skaičius: 4. Šiame puslapyje — kaina ir grafikas, dividendai, didžiausi akcininkai ir akcijų skaičiaus istorija.

⚠ Nesupainiokite jų: yra kita įmonė su tokiu pačiu arba labai panašiu pavadinimu. Tai atskiras įrašas – patikrinkite biržą, biržos ir registracijos numerį.
  • Grifols SA — GRF-P · MC ES Registracijos numeris nežinomas

Apie Įmonę

Svetainė
grifols.com
Investuotojams
grifols.com/en/investors
Sektorius
Healthcare · Drug Manufacturers - General
Būstinė
NEW YORK, Spain
Generalinis Direktorius
Jose Ignacio Abia Buenache
Darbuotojai
25 258
Įkurta
1909
Biržoje Nuo
23.11.2007 (LSE:0RDU)
Apyvartoje Esančios Akcijos
422.36 mln.
Laisvai Apyvartinės Akcijos
418.2 mln.
Rinkos Kapitalizacija
7.57 mlrd. USD
Insaideriai
31.19%
Instituciniai Investuotojai
37.75%
Šaka (SIC)
Pharmaceutical Preparations
Teisinė Forma
5RDO
ISIN
ES0171996012
LEI
959800HSSNXWRKBK4N60
Išmokų Santykis
≈7.7%
FCF
641 mln. EUR
Išmokėjimas / FCF
5%
Skola
8.52 mlrd. EUR
11 m. FCF
Dividendų Stažas
1 m.
Pelnas, FCF ir dividendai – už 12 mėnesių iki 30.06.2026 (naujausia įmonės ataskaita).
Aprašymas

Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain.

reklama

Biržos ir Tikeriai

BiržaTikerisValiutaKainaTipas
US USA StocksGIFLF OTCUSD10.547 -5.24%paprastosios akcijos
LSE London Stock Exchange0RDU IOBEUR16.125 +0.00%paprastosios akcijos
MC Bolsa de MadridGRF pagrindinisEUR9.8 +1.43%paprastosios akcijos
VI Vienna Stock ExchangeGRF papildomasEUR9.962 +0.99%paprastosios akcijos

Kaina per 3 Mėnesius

kilimo diena kritimo diena dividendų ex data išmokėjimo dataUžveskite / palieskite dieną — atidarymo, uždarymo, aukščiausia ir žemiausia kainos

Dividendai

Grifols S.A (GIFLF) dividendus moka kartą per metus.

Ex DataIšmokaSuma%TipasTikeris
2026-07-012026-07-020.0824 EUR0.9 %specialusUS:GIFLF
2025-08-122025-08-130.1500 EUR1.2 %specialusUS:GIFLF

Didžiausi Akcininkai

TurėtojasDalisAkcijosAtaskaitos Data
VANGUARD STAR FUNDS-Vang…1%4.28 mln.2026-04-30
VANGUARD TAX-MANAGED FUN…0.66%2.8 mln.2026-06-30
iShares Trust-iShares Co…0.49%2.08 mln.2026-07-31
DFA INVESTMENT DIMENSION…0.34%1.46 mln.2026-04-30
Dimensional ETF Trust-Di…0.25%1.07 mln.2026-04-30
iShares Trust-iShares MS…0.22%935 1282026-07-31
DFA INVESTMENT TRUST CO-…0.17%741 7722026-04-30
VANGUARD Intl Eqy. INDEX…0.16%696 5102026-04-30
SCHWAB STRATEGIC TRUST-S…0.16%676 4822026-05-31
VANGUARD Intl Eqy. INDEX…0.15%634 2982026-04-30
Pacer Advisors, Inc.0%1 3232026-06-30